When sleep stops: subtherapeutic buprenorphine-naloxone and severe central sleep apnea

Abstract Background Central sleep apnea (CSA) is a recognized complication of opioid use, yet its occurrence in individuals using subtherapeutic and/or inconsistent doses of buprenorphine-naloxone remain underreported. This case highlights the development of severe CSA in a patient with opioid use d...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Shaheryar Usman, Ricardo Concepción, Adrienne Kathleen DaGue, Amira Dalmazio, Lilit Sargsyan
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2025-11-01
coleção:	Sleep Science and Practice
Assuntos:	Suboxone Buprenorphine-naloxone Central sleep apnea Subtherapeutic Adaptive servo-ventilation Obstructive sleep apnea
Acesso em linha:	https://doi.org/10.1186/s41606-025-00154-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!